Qiang Wen Selected Research

des-aspartate-angiotensin I

12/2015	Des-aspartate-angiotensin I causes specific release of PGE2 and PGI2 in HUVEC via the angiotensin AT1 receptor and biased agonism.
5/2011	Effects of des-aspartate-angiotensin I on myocardial ischemia-reperfusion injury in rats.
8/2004	Reduction of infarct size by orally administered des-aspartate-angiotensin I in the ischemic reperfused rat heart.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Qiang Wen Research Topics

Disease

18	Neoplasms (Cancer) 01/2022 - 06/2012
7	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 05/2016
7	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 07/2015
5	Heat Stroke (Heatstroke) 01/2021 - 05/2011
4	Thyroid Neoplasms (Thyroid Cancer) 10/2021 - 01/2015
4	Infections 03/2016 - 01/2010
3	Ovarian Neoplasms (Ovarian Cancer) 01/2022 - 09/2017
3	Inflammation (Inflammations) 01/2021 - 10/2011
3	Papillary Thyroid Cancer 10/2019 - 01/2018
3	Type 2 Diabetes Mellitus (MODY) 01/2019 - 01/2012
2	Pneumonia (Pneumonitis) 01/2022 - 01/2019
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2021 - 01/2018
2	Lymphatic Metastasis 01/2021 - 01/2015
2	Carcinogenesis 01/2018 - 01/2018
2	Fibrosis (Cirrhosis) 12/2017 - 08/2016
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2017 - 12/2015
2	Myocardial Infarction 02/2015 - 05/2011
2	Multiple Trauma (Multiple Injuries) 01/2014 - 02/2009
2	Infarction (Infarctions) 05/2011 - 08/2004
2	Sepsis (Septicemia) 03/2009 - 11/2006
2	Multiple Organ Failure (MODS) 03/2009 - 02/2009
1	Radiation Pneumonitis 01/2022
1	Down Syndrome (Down's Syndrome) 01/2021
1	Prostatic Neoplasms (Prostate Cancer) 01/2021
1	Alzheimer Disease (Alzheimer's Disease) 01/2021
1	Esophageal Neoplasms (Esophageal Cancer) 10/2019
1	Esophageal Fistula 10/2019
1	Neutropenia 01/2019
1	Liver Diseases (Liver Disease) 01/2019
1	Capillary Hemangioma 01/2019
1	Disease Progression 01/2019
1	Leukopenia 01/2019
1	Myocarditis (Carditis) 01/2019
1	Hypothyroidism 01/2019
1	Hyperplasia 01/2019
1	Fatigue 01/2019
1	Mouth Neoplasms (Oral Cancer) 07/2018
1	Adenocarcinoma of Lung 07/2018
1	Leukemia 01/2018

Drug/Important Bio-Agent (IBA)

4	CytochromesIBA 01/2021 - 05/2016
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 05/2011
3	Long Noncoding RNAIBA 12/2021 - 01/2019
3	Cytochrome P-450 CYP2D6 (CYP2D6)IBA 01/2021 - 08/2016
3	MicroRNAs (MicroRNA)IBA 01/2021 - 10/2015
3	Pharmaceutical PreparationsIBA 01/2017 - 03/2016
3	Interleukin-6 (Interleukin 6)IBA 12/2016 - 02/2009
3	des-aspartate-angiotensin IIBA 12/2015 - 08/2004
3	HLA-DR Antigens (HLA-DR)IBA 01/2015 - 11/2006
2	Cytochrome P-450 CYP2E1 (CYP2E1)IBA 01/2022 - 12/2017
2	Sirtuin 1IBA 10/2021 - 02/2018
2	camrelizumabIBA 01/2019 - 01/2019
2	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2017 - 07/2015
2	HLA Antigens (Human Leukocyte Antigens)IBA 01/2017 - 11/2006
2	AngiotensinsIBA 12/2015 - 08/2004
2	Proteins (Proteins, Gene)FDA Link 07/2015 - 10/2011
2	Interleukin-33IBA 02/2015 - 01/2015
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2015 - 02/2009
2	Phosphotransferases (Kinase)IBA 08/2012 - 06/2012
2	Indicators and Reagents (Reagents)IBA 02/2012 - 10/2011
2	urinastatin (MR 20)IBA 06/2011 - 03/2009
2	AntigensIBA 01/2010 - 11/2006
1	hepsinIBA 01/2022
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 01/2022
1	Oxidoreductases (Dehydrogenase)IBA 01/2022
1	STAT4 Transcription FactorIBA 01/2022
1	ChemokinesIBA 01/2021
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2021
1	B7-H1 AntigenIBA 01/2021
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2021
1	gallium 68 PSMA-11IBA 01/2021
1	LigandsIBA 01/2021
1	Miat long non-coding RNAIBA 10/2019
1	Tyrosine Kinase InhibitorsIBA 02/2019
1	Gefitinib (Iressa)FDA Link 02/2019
1	ErbB Receptors (EGF Receptor)IBA 02/2019
1	apatinibIBA 01/2019
1	IodineIBA 01/2019
1	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2019
1	Small Nucleolar RNA (snoRNA)IBA 01/2019
1	Biological ProductsIBA 01/2019
1	Liraglutide FDA Link 01/2019
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 11/2018
1	anthraceneIBA 11/2018
1	Celecoxib (Celebrex)FDA Link 11/2018
1	Insulin-Like PeptidesIBA 09/2018
1	Keratin-17 (Keratin 17)IBA 07/2018
1	Leucine (L-Leucine)FDA Link 01/2018

Therapy/Procedure

9	Therapeutics 01/2022 - 03/2009
5	Chemoradiotherapy 01/2022 - 07/2015
3	Immunotherapy 01/2022 - 01/2022
2	Radiotherapy 10/2019 - 05/2013
2	Drug Therapy (Chemotherapy) 09/2017 - 05/2013
2	Artificial Respiration (Mechanical Ventilation) 01/2014 - 03/2009
2	Liver Transplantation 01/2010 - 08/2008
1	Lymph Node Excision (Lymph Node Dissection) 01/2021
1	Prostatectomy (Retropubic Prostatectomy) 01/2021
1	Fecal Microbiota Transplantation 01/2019
1	Salvage Therapy 01/2019